ArrayExpress Uploaderarrayexpress_sidhumanisolated limb infusion w/ melphalanstable disease SDnot specifiedisolated limb infusion w/ melphalancomplete response CRnot specifiedisolated limb infusion w/ melphalancomplete response CRBraf-WT Nras-mutantisolated limb infusion w/ melphalannon-evaluable n.e.not specifiedisolated limb perfusion w/ melphalannon-evaluable n.e.not specifiedisolated limb perfusion w/ melphalancomplete response CRBraf-mutant Nras-WTisolated limb perfusion w/ melphalanprogressive disease PDnot specifiedisolated limb perfusion w/ melphalanprogressive disease PDnot specifiedisolated limb perfusion w/ melphalanprogressive disease PDBraf-mutant Nras-WTisolated limb perfusion w/ melphalancomplete response CRBraf-mutant Nras-WTisolated limb perfusion w/ melphalannon-evaluable n.e.not specifiedisolated limb perfusion w/ melphalannon-evaluable n.e.not specifiedisolated limb perfusion w/ melphalannon-evaluable n.e.not specifiedisolated limb infusion w/ melphalannon-evaluable n.e.not specifiedisolated limb infusion w/ melphalancomplete response CRnot specifiedisolated limb infusion w/ melphalanprogressive disease PDnot specifiedisolated limb infusion w/ melphalanpartial response PRnot specifiedisolated limb perfusion w/ melphalancomplete response CRBraf-WT Nras-mutantisolated limb infusion w/ melphalanprogressive disease PDnot specifiedisolated limb infusion w/ melphalancomplete response CRnot specifiedisolated limb infusion w/ melphalanstable disease SDnot specified435004An evaluation of biopsies from patients with in-transit extremity melanoma who have been treated with melphalan in the setting of...E-GEOD-34599/profile/8773/arrayexpressuploader321diseaselimbmelanomaDec.12, 2014Falsein-transit-extremity-melanoma-iiiE-GEOD-34599_A-AFFY-44In-transit extremity melanoma IIISep.17, 2014An evaluation of biopsies from patients with in-transit extremity melanoma who have been treated with melphalan in the setting of isolated limb infusion or isolated limb perfusion. Gene expression profiles were obtained from 21 lesions across 19 patients and evaluated for expression that correlated with response to melphalan isolated limb infusion. Chemotherapy response analysis: complete response - CR; partial response - PR; stable disease - SD; progressive disease - PD; not evaluable - n.e.http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-34599http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-34599/samples/